Exelixis Inc (EXEL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

1851 HARBOR BAY PARKWAY ALAMEDA, CA 94502

Uses comparative genomics and model system genetics to identify novel genes or proteins that represent potential product targets or drugs to treat disease or prevent disease initiation or progression. The company's most advanced pharmaceutical program focuses on small molecules in cancer.

Data as of 2020-09-12
Market Cap6.714 Billion Shares Outstanding308.996 Million Avg 30-day Volume1.658 Million
P/E Ratio23.5 Dividend Yield EPS0.89
Price/Sales6.725 Price cash flow ratio16.9 Price free cash flow ratio17.3
Book Value5.93 Price to Tangible Book3.65 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.123944
BETA1.39522 52-week High/Low27.8 / 13.67 Stddev0.169332
View SEC Filings from EXEL instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 4 0.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 366 331 10.57% 84 (5.48%) 70 (4.48%) 20.0%
13F shares: 252.359 Million 246.702 Million 2.29% 71.906 Million 68.894 Million 4.37%
% Ownership 81.6705 80.6919 1.21% 23.2709 22.5341 3.27%
New Positions: 80 52 53.85% 28 15 86.67%
Increased Positions 121 119 1.68% 29 29 0.0%
Closed Positions 41 42 -2.38% 13 16 -18.75%
Reduced Positions 112 100 12.0% 23 22 4.55%
Total Calls 1.06 Million 1.354 Million -21.68% 254.7 Thousand 545 Thousand -53.27%
Total Puts 763.486 Thousand 891.608 Thousand -14.37% 93.4 Thousand 261.5 Thousand -64.28%
PUT/CALL Ratio 0.72 0.66 9.09% 0.37 0.48 -22.92%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EXEL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EXEL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

40 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

434.8 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HESSEKIEL JEFFREY EVP AND GENERAL COUNSEL

  • Officer
344,025 2020-09-16 7

SENNER CHRISTOPHER J. EVP AND CFO

  • Officer
130,605 2020-09-15 5

MORRISSEY MICHAEL PRESIDENT AND CEO

  • Officer
  • Director
1,152,468 2020-09-02 22

SCHWAB GISELA PRES, PROD DEV & MED AFF & CMO

  • Officer
348,071 2020-09-02 12

LAMB PETER EVP, SCIENTIFIC STRATEGY & CSO

  • Officer
150,683 2020-09-02 6

HALEY PATRICK J. EVP, COMMERCIAL

  • Officer
149,758 2020-09-02 11

COHEN CHARLES

  • Director
181,375 2020-09-01 3

POSTE GEORGE

  • Director
157,992 2020-08-14 3

WILLSEY LANCE

  • Director
0 2020-05-21 3

WYSZOMIERSKI JACK L

  • Director
169,406 2020-05-21 2

FELDBAUM CARL B

  • Director
0 2020-05-21 3

GARBER ALAN M

  • Director
12,718 2020-05-21 3

MARCHESI VINCENT T

  • Director
90,212 2020-05-21 3

PAPADOPOULOS STELIOS

  • Director
1,188,897 2020-05-21 3

SMITH JULIE

  • Director
16,301 2020-05-21 1

FREIRE MARIA C

  • Director
40,102 2020-05-21 1

SCANGOS GEORGE A

  • Director
738,312 2020-05-18 12

BURKE DEBORAH SVP & CHIEF FINANCIAL OFFICER

  • Officer
19,990 2014-11-15 0

SIMONTON PAMELA A EVP, EXELIXIS

  • Officer
28,091 2014-02-15 0

KARBE FRANK EVP AND CFO

  • Officer
105,839 2014-02-15 0

MCCORMICK FRANK

  • Director
0 2013-12-06 0

GARLAND J. SCOTT EVP & CHIEF COMMERICAL OFFICER

  • Officer
0 2013-09-18 0

RIVERA LUPE M EVP, OPERATIONS

  • Officer
22,051 2011-08-15 0

HELLER FRANCES K EVP, BUSINESS DEVELOPMENT

  • Officer
17,254 2011-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-16 20:24:41 -0400 2020-09-16 M 20,000 d 110,000 direct

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-16 20:24:41 -0400 2020-09-16 S 20,000 $26.11 d 343,026 direct yes -0.5197 0.0 1 -0.5197 2

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-16 20:24:41 -0400 2020-09-16 M 20,000 $7.27 a 363,026 direct -0.5197 0.0 1 -0.5197 2

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2020-09-15 20:03:52 -0400 2020-09-15 M 20,000 d 130,000 direct

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2020-09-15 20:03:52 -0400 2020-09-15 S 20,000 $25.00 d 127,882 direct yes 1.1641 1.1641 2 0.0 1

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2020-09-15 20:03:52 -0400 2020-09-15 M 20,000 $3.66 a 147,882 direct 1.1641 1.1641 2 0.0 1

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-10 20:39:36 -0400 2020-09-08 M 190,000 d 0 direct

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-10 20:39:36 -0400 2020-09-08 M 190,000 $6.21 a 503,692 direct 13.8058 23.3318 23.9761 5 0.0 1

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-10 20:39:36 -0400 2020-09-08 M 59,692 d 20,000 direct

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-10 20:39:36 -0400 2020-09-08 M 59,692 $1.90 a 313,692 direct 13.8058 23.3318 23.9761 5 0.0 1

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-10 20:39:36 -0400 2020-09-08 F 160,666 $20.71 d 343,026 direct 13.8058 23.3318 23.9761 5 0.0 1

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2020-09-04 18:36:04 -0400 2020-09-02 A 9,745 a 130,448 direct 2.1009 21.3716 21.3716 6 0.0 1

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2020-09-04 18:40:12 -0400 2020-09-02 F 1,116 $21.58 d 115,571 direct 2.1009 21.3716 21.3716 6 0.0 1

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2020-09-04 18:41:24 -0400 2020-09-02 A 9,370 a 135,901 direct 2.1009 21.3716 21.3716 6 0.0 1

SCHWAB GISELA - Officer PRES, PROD DEV & MED AFF & CMO

2020-09-04 18:32:57 -0400 2020-09-02 F 2,517 $21.58 d 333,191 direct 2.1009 21.3716 21.3716 6 0.0 1

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-04 18:38:59 -0400 2020-09-02 F 1,311 $21.58 d 254,000 direct 2.1009 21.3716 21.3716 6 0.0 1

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2020-09-04 18:40:12 -0400 2020-09-02 A 4,498 a 116,687 direct 2.1009 21.3716 21.3716 6 0.0 1

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2020-09-04 18:31:31 -0400 2020-09-02 F 6,118 $21.58 d 103,105 direct 2.1009 21.3716 21.3716 6 0.0 1

SCHWAB GISELA - Officer PRES, PROD DEV & MED AFF & CMO

2020-09-04 18:32:57 -0400 2020-09-02 A 9,745 a 335,708 direct 2.1009 21.3716 21.3716 6 0.0 1

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2020-09-04 18:36:04 -0400 2020-09-02 F 2,566 $21.58 d 127,882 direct 2.1009 21.3716 21.3716 6 0.0 1

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2020-09-04 18:38:59 -0400 2020-09-02 A 4,998 a 255,311 direct 2.1009 21.3716 21.3716 6 0.0 1

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2020-09-04 18:41:24 -0400 2020-09-02 F 2,323 $21.58 d 133,578 direct 2.1009 21.3716 21.3716 6 0.0 1

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2020-09-04 18:31:31 -0400 2020-09-02 A 23,238 a 109,223 direct 2.1009 21.3716 21.3716 6 0.0 1

COHEN CHARLES - Director

2020-09-03 20:05:34 -0400 2020-09-01 M 115,396 $5.82 a 181,375 direct 0.1693 19.642 19.642 6 0.0 1

COHEN CHARLES - Director

2020-09-03 20:05:34 -0400 2020-09-01 M 115,396 d 0 direct

POSTE GEORGE - Director

2020-08-14 19:50:37 -0400 2020-08-14 M 29,662 $5.82 a 157,992 direct -0.6605 -4.7116 0.0 1 -4.7116 6

POSTE GEORGE - Director

2020-08-14 19:50:37 -0400 2020-08-14 M 29,662 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments